European Index Futures Little Changed; Ryanair May Move


European stock-index futures were little changed after the region’s equities climbed for a fifth week. U.S. stock-index futures were also little changed, while Asian shares fell.

Deutsche Bank AG may move after Germany’s biggest bank sold about 60 million shares to the Qatari royal family as it announced plans to raise 8 billion euros ($11 billion) in its second-biggest capital increase. AstraZeneca (AZN) Plc may be active after it rejected Pfizer Inc.’s final increased bid to buy the U.K. drugmaker. Ryanair Holdings Plc may move after the discount carrier reported its first annual profit drop in five years.

Futures on the Euro Stoxx 50 Index expiring in June slipped less than 0.1 percent to 3,150 at 7:15 a.m. in London. Contracts on the U.K.’s FTSE 100 Index gained less than 0.1 percent, while Standard & Poor’s 500 Index futures (SX5E) lost 0.1 percent. The MSCI Asia Pacific Index dropped 0.4 percent.

The Stoxx Europe 600 Index added 0.1 percent last week as euro-area economic growth missed estimates and investors watched mixed earnings reports. The stocks gauge climbed for five straight weeks, the longest streak since November 2013, and reached a six-year high on May 13.

Deutsche Bank may be active. Paramount Holdings Services Ltd., an investment vehicle of Qatar, purchased 1.75 billion euros of shares at 29.20 euros each, the lender said in a statement last night. Deutsche Bank will raise an additional 6.3 billion euros from a rights offer in June, it said.

Sweetened Bid

AstraZeneca may move after rejecting a final increased bid by Pfizer. The U.S. company boosted its offer to 69.4 billion pounds ($117 billion), valuing the London-based company at 55 pounds a share. On May 2, Pfizer offered 50 pounds a share, following a previous bid made in January. Pfizer said the new offer would be its last under the current process.

Ryanair (RYA) may be active. Profit after tax fell 8 percent to 523 million euros in the year ended March 31, the airline said. That fell short of the average analyst estimate of 521 million euros. Sales climbed 3 percent to 5.04 billion euros.

Saab AB may move. The company stands to lose a 3.1 billion-franc ($3.5 billion) order for Gripen fighter jets after Swiss voters rejected the deal in a referendum. The 22-plane contract, which 2 1/2 years ago, was opposed by 53.4 percent of voters, the Swiss government in Bern said yesterday.


Please enter your comment!
Please enter your name here